Crohn’s Disease Biomarker Appears Years Ahead of Diagnosis
Medscape Medical News: Miguel Regueiro, professor at the School of Medicine, discussed autoantibodies and how new research shows they may predict Crohn’s disease years before symptoms appear. “Finally, it’s possible that this could lead to specialized treatment that is targeted to the patients with this biomarker. This could be the precision medicine to improve remission rates too much higher than we see today with our current therapies,” said Regueiro.